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Background: Asthma is a chronic inflammatory disease of the airways with a complex genetic 
background. In this study, we carried out a meta-analysis of single nucleotide polymorphisms 
(SNPs) thought to be associated with asthma.
Methods: The literature (PubMed) was searched for SNPs within genes relevant in asthma. 
The SNP-modified genes were converted to corresponding proteins, and their protein–protein 
interactions were searched from six different databases. This interaction network was analyzed 
using annotated vocabularies (ontologies), such as the Gene Ontology and Nature pathway 
interaction databases.
Results: In total, 127 genes with SNPs related to asthma were found in the literature. The 
corresponding proteins were then entered into a large protein–protein interaction network with 
the help of various databases. Ninety-six SNP-related proteins had more than one interacting 
protein each, and a network containing 309 proteins and 644 connections was generated. This 
network was significantly enriched with a gene ontology entitled “protein binding” and several 
of its daughter categories, including receptor binding and cytokine binding, when compared 
with the background human proteome. In the detailed analysis, the chemokine network, includ-
ing eight proteins and 13 toll-like receptors, were shown to interact with each other. Of great 
interest are the nonsynonymous SNPs which code for an alternative amino acid sequence of 
proteins and, of the toll-like receptor network, TLR1, TLR4, TLR5, TLR6, TLR10, IL4R, and 
IL13 are among these.
Conclusions: Protein binding, toll-like receptors, and chemokines dominated in the asthma-
related protein interaction network. Systems level analysis of allergy-related mutations can 
provide new insights into the pathogenetic mechanisms of disease.
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Introduction
Asthma is a chronic inflammatory disease of the airways characterized by infiltration 
and activation of inflammatory cells and by structural changes, including subepithelial 
fibrosis, smooth muscle cell hypertrophy/hyperplasia, epithelial cell metaplasia, and 
angiogenesis. These structural changes are believed to correlate with the severity of 
asthma and to some extent with the development of progressive lung function dete-
rioration. The mechanism underlying airway angiogenesis in asthma and its precise 
clinical relevance has not yet been completely elucidated.1
Asthma may best be described as a loosely defined syndrome characterized by 
respiratory symptoms, airways narrowing, and inflammation. Asthma is a common 
pulmonary condition that involves heightened bronchial hyperresponsiveness and Journal of Asthma and Allergy 2010:3 submit your manuscript | www.dovepress.com
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reversible bronchoconstriction, together with acute-on-
chronic inflammation that leads to airways remodeling. The 
most common causes predisposing for asthma include viral 
upper respiratory tract infections, cigarette smoke, cold 
temperatures, allergies, pets, and exercise. Symptoms of 
asthma include wheezing, intercostal and supraclavicular 
retraction, cough (worse at night), shortness of breath, chest 
pain, exercise intolerance, and limitation of daily activities, 
which should alert physicians to a diagnosis of possible 
asthma or an asthma exacerbation.2,3
Allergic asthma is characterized by a specific pattern of 
inflammatory attributes driven by IgE-dependent   triggering 
of resident tissue mast cells and characterized by the influx 
of basophils and eosinophils in inflamed airways. The inter-
action between inflammatory cells and structural cells in 
asthmatic airways is complex. Several cytokines and growth 
factors released during allergic airway inflammation and 
remodeling are responsible for increasing basal levels of 
vascular endothelial growth factor in fibroblasts and smooth 
muscle cells.1,4,5
In spite of its great burden on public health care, our 
knowledge of the etiologic mechanisms underlying asthma, 
both genetic and environmental, is still very limited. One 
of the most promising approaches to expand further our 
understanding of the disease mechanisms involved is iden-
tification of the genetic variation that contributes to the risk 
of developing asthma.6
In recent years, research has mainly focused on detect-
ing the genetic variations that predispose the individual 
to asthma. Three basic types of genetic study have been 
undertaken, ie, genetic linkage analysis, searches for focused 
candidate genes, and the modern genome-wide association 
studies performed with single nucleotide polymorphism 
(SNP) chips. Extensive epidemiologic studies have made 
little progress in determining the individual’s susceptibility 
to asthma. The molecular genetic studies of asthma offer the 
prospect of defining this susceptibility at a genetic level, and 
allow more precise studies on the etiology of asthma to be 
undertaken.7–9
Family studies using linkage methodologies conducted to 
date have not been very successful in identifying the genetic 
determinants of this complex disease.10 The revolution in 
genotyping technology with high-throughput methods now 
allows genotyping of greater numbers of SNPs in large cohort 
genome-wide association studies. Most of the genes uncov-
ered during recent years with the genome-wide approach are 
novel, and were not even considered in the old candidate gene 
studies. Asthma is an example of a complex disease where 
several common susceptibility alleles affect the disease risk 
in varying combinations, but in a manner such that each gene 
contributes only a minor impact.11 The downstream biologic 
effects of the majority of these genes and their proteins are 
still unknown. Expression studies of these genes and proteins 
could allow us to uncover some of their effects.12
If some of the unexplained heritability in genome-wide 
association studies was due to interactions then, rather than 
discovering interactions per se, one goal might be to use these 
interactions in order to discover novel genes that act syner-
gistically with other factors without having demonstrable 
marginal effects.13
Materials and methods
Literature search
A literature search in PubMed (http://www.ncbi.nlm.nih.
gov/pubmed) was carried out in September 2009 with the 
search phrase “asthma and SNP”. The list obtained was 
then manually annotated, and a list of SNP modifications 
in asthma was collected. Even though this is probably not 
a complete list, it gives a very good idea of the found and 
proposed SNP modifications linked to asthma. The list of 
SNPs claimed to be associated with asthma (Table 1) was 
used for further analyses.
Protein–protein interaction networks
We used a web-based protein interaction network analysis 
platform (PINA), which integrates protein–protein interaction 
data from six databases. The Cytoscape757 program provides 
a network construction tool, which uses our protein–protein 
interaction data as the baseline. The SwissProt names without 
the tag “__HUMAN” are used throughout this study, if not 
otherwise stated.
The gene ontology categories provide a controlled vocab-
ulary to describe the gene and the gene product attributes of 
any organism. The enrichment analysis of proteins in the 
various gene ontology (GO Slim) categories was carried out 
essentially as described elsewhere.14–16
When the analysis within these annotated categories was 
carried out, we searched for enriched categories. The basic 
question was: Is the category “toll-like receptors” or the key 
phrase “cytokine–cytokine receptor interaction” within the 
observed SNP-related network enriched when compared 
with the background set of the whole human proteome? If 
such a phenomenon was observed, it could suggest that these 
enriched categories and keywords play a role within the SNP-
related protein network found in asthma patients.Journal of Asthma and Allergy 2010:3 submit your manuscript | www.dovepress.com
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Table 1 A list of 127 genes and their corresponding proteins, where snP(s) have been found to relate to allergic diseases
GENE PROTEIN PMID ALOX5AP AL5AP 18547289 TGFB1 TGFB1 17333284
ARg1 ARgi1 19281908 LTA4H LKHA4 18547289 iL27 iL27A 17318299
ARG2 ARGI2 19281908 CTTN SRC8 18521921 MYLK MYLK 17266121
IL10 IL10 19222424 PTGS2 PGH2 18489027 CD40 TNR5 17255560
PPARG PPARG 19217272 PTPRD PTPRD 18414509 CCL11 CCL11 17220216
IL1RL1 ILRL1 19198610 cRhR2 cRFR2 18408560 cYsLTR1 cLTR1 17154652
WDR36 WDR36 19198610 chi3L1 ch3L1 18403759 cYsLTR2 cLTR2 17154652
IL33 IL33 19198610 IL4 IL4 18396027 CCR5 CCR5 17154652
MYB MYB 19198610 iFng iFng 18385742 SOCS1 SOCS1 17099141
cTnnA3 cTnA3 19187332 IL18R1 IL18R 18382474 IL9R IL9R 17083349
TLR2 TLR2 19148143 GSTP1 GSTP1 18335111 RIPK2 RIPK2 17075290
ADAM33 ADA33 19146844 TLR9 TLR9 18312481 CHRM1 ACM1 16931638
CD14 CD14 19096003 nPsR1 B7ZMA2 18305139 IL7R IL7RA 16890764
hLX1 hLX 19038437 TNC TENA 18305139 LIFR LIFR 16890764
TNF TNFA 19004142 NPPA ANF 18294255 AOAH AOAH 16815140
GSTM1 GSTM1 18988661 IL18 IL18 18200581 PDGFRA PGFRA 16804324
CMA1 CMA1 18973102 INPP4A INP4A 18187694 nPs nPs 16790440
CXCR3 CXCR3 18962861 UgRP1 sg3A2 18089940 sFRs8 sFRs8 16738036
cRTh2 gPR44 18946232 CCR3 CCR3 17983872 MMP-9 MMP-9 16631427
IL6 IL6 18810365 IL5RA IL5RA 17983872 ICAM1 ICAM1 16625213
IL1RN IL1RA 18810365 FCER2 FCER2 17980418 MBL2 MBL2 16487239
iL21 iL21 18802358 EDN1 EDN1 17960156 DEFB1 DEFB1 16435024
iL1B iL1B 18773331 TBX21 TBX21 17949803 IL16 IL16 16387589
MYLK MYLK 18766098 PTgeR3 Pe2R3 17877755 ALOX5 LOX5 16361798
ORMDL3 ORML3 18754760 HLA-G HLAG 17847008 C3 CO3 16355111
ACE ACE 18727619 PhF11 PhF11 17702965 TLR4 TLR4 16215326
CYBA CY24A 18716406 TgF-beta1 TgFB1 17673695 DPP10 DPP10 15986064
SERPINE1 PAI1 18714537 KAT5 KAT5 17672871 LTA TnFB 15969671
ccL24 ccL24 18712274 gcLc gsh1 17643973 GATA3 GATA3 15637551
CCL26 CCL26 18712274 HAVCR1 TIMD1 17570927 cLcA1 cLcA1 15318163
CCL17 CCL17 18691306 ITGB3 ITB3 17556058 TLR10 TLR10 15201134
MS4A2 FCERB 18691306 ADh5 ADhX 17543375 DAP3 RT29 15179560
IL13 IL13 18691306 PTGDR PD2R 17538632 IL15 IL15 15131572
IL4R IL4RA 18691306 STAT4 STAT4 17532201 NOS1 NOS1 14767694
TLR7 TLR7 18682521 STAT6 STAT6 17519224 TAP1 TAP1 12640628
TLR8 TLR8 18682521 PTgeR2 Pe2R2 17496729 CTLA4 CTLA4 12417883
GRK5 GRK5 18622265 PTgeR4 Pe2R4 17496729 AicDA AicDA 11544457
chiA chiA 18602573 PTGIR PI2R 17496729 CCL2 CCL2 11544456
FCER1G FCERG 18595682 TBXA2R TA2R 17496729 IKBKAP ELP1 11281413
FCER1A FCERA 18595682 TNF TNFA 17450233 C5 CO5 10973279
ADRB2 ADRB2 18558635 SFTPA2 SFPA2 17407567 CCL5 CCL5 11197694
TLR1 TLR1 18547625 PLAU UROK 17363771 LTC4S LTC4S 10970818
TLR6 TLR6 18547625 RnAse3 ecP 17362255
Notes: The proteins displayed on the common pathway as shown in Figure 2 are marked in bold. The swissProt names for proteins are used without the tag _hUMAn 
throughout the study.
Results
We first searched the literature published for 2000–2009 on 
the association of SNPs with asthma. The search produced 
251 articles, from which a list of 127 genes and their corre-
sponding proteins linked to asthma was compiled (Table 1). 
Next, we generated a protein–protein interaction network for 
these 127 proteins. The interacting protein partners for each 
of these proteins were searched with PINA, which integrates 
six different protein–protein interaction databanks.17
We first pulled down all the protein–protein interac-
tions of these putatively asthma-related proteins, which 
resulted in a very large network with 1073 proteins (nodes) 
and 1421 connections (edges) between them. This large 
data set was imported to Cytoscape and the network is 
displayed in   Figure 1A.18 In order to facilitate data mining 
within the   protein–protein interaction network, we created 
a more stringent query yielding a smaller subset of the 
original large network. This new limited network contained Journal of Asthma and Allergy 2010:3 submit your manuscript | www.dovepress.com
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interacting proteins which were bound to at least two other 
proteins identified to carry asthma-related SNP modifica-
tions in their corresponding genes. This data set contained 
only 309   proteins (96 of which were SNP-related proteins, 
213 interacting proteins, and 644 connections between them, 
Figure 1B).
Because such a network is far too large to be analyzed 
visually in a meaningful manner, we decided to perform 
a gene ontology enrichment analysis. When the analysis 
within the gene ontology-molecular function categories was 
performed, several strongly enriched classes were observed, 
as shown in Table 2. “Protein binding” and several of its 
daughter categories, including receptor binding, cytokine 
binding, growth factor binding, interleukin binding, transcrip-
tion factor binding, chemokine binding, and pattern binding, 
were among the most significantly enriched categories. 
Furthermore, protein kinase activity, including tyrosine and 
serine/threonine kinase activity, as well as endopeptidase 
activity, was significantly enriched within the asthma-related 
SNP-modified genes and their corresponding proteins.
To utilize this asthma-related network further, we 
searched for connections between the asthma-related SNP 
proteins only (Figure 2). The results showed that while 31 of 
the 96 proteins do not interact with any other SNP protein, 
14 interact with each other, 20 form a pair, two triplets, 
one a quartet, and two larger networks contain several con-
nected asthma-related SNP proteins. The chemokine network 
includes eight proteins and the toll-like receptor network 13 
Figure 1 A) The protein–protein binding network is built on the basis on two sources of data, ie, the asthma pathogenesis literature published on the putative association 
of single nucleotide polymorphisms within genes coding corresponding proteins and the protein–protein interaction network data for all these proteins. The original dataset 
from the literature with 127 genes with single nucleotide polymorphism modifications were converted to corresponding proteins (synonymous marked as green and 
nonsynonymous marked as red nodes). The interacting protein partners for each of these proteins (yellow nodes) were searched using protein interaction network analysis. 
B) The Figure 1A network was modified so that each interacting protein (yellow nodes) binds to at least two (synonymous marked as green and nonsynonymous marked as 
red nodes) single nucleotide polymorphism proteins. A Cytoscape file can be loaded from the online supporting information. All the proteins are marked with the SwissProt 
name, but without the tag “_hUMAn” for clarity (see Table 1).
proteins, all shown to carry asthma-related SNP   modifications 
among their corresponding genes. We expanded to the most 
interesting networks with PINA and were able to create two 
new networks in Cytoscape. The chemokine network (green 
proteins, Figure 3) shows eight asthma-related SNP proteins 
binding to each other. Furthermore, a great number of other 
chemokines and their receptors also show an interaction 
within this network (yellow proteins, Figure 3).
Likewise, the other new subnetwork displays 13 asthma-
related SNP proteins interacting with each other (Figure 4). 
This toll-like receptor/cytokine network also contains a 
large group of novel proteins, including toll-like receptors 
and cytokines, as well as signal transduction molecules 
(yellow proteins, Figure 4). Such an enlarged network of 
interacting proteins could putatively be used to search for 
novel proteins having a crucial role in the development of 
asthma-related inflammatory reactions. Of great interest are 
the nonsynonymous SNPs, which code for an alternative 
amino acid sequence of proteins. The red proteins within 
Figure 4, ie, TLR1, TLR4, TLR5, TLR6, TLR10, and IL4R 
and IL13, are among these. This small subnetwork of toll-like 
receptor-related proteins and their 40 interacting proteins was 
further analyzed. This analysis showed that these 40 inter-
acting proteins have already been reported to carry almost 
1000 nonsynonymous SNPs coding for alternative protein 
sequences (Table 3).
Finally, we manually annotated the whole set of 309 
proteins in Figure 1B. A thorough analysis showed that the Journal of Asthma and Allergy 2010:3 submit your manuscript | www.dovepress.com
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most common class of annotations for these proteins was 
“cytokine–cytokine receptors”. We have generated a network 
of these proteins in Figure 5 (green proteins) and enlarged the 
pathway by also including their interacting proteins (yellow 
proteins, Figure 5). A strong input of other chemokines and 
signal transduction proteins is also seen here.
Discussion
Asthma is a major burden for health care worldwide. 
Although the pathophysiology of asthma has been studied 
intensively during recent years, much more work needs to 
be done before it will be possible to prevent the onset of 
symptoms of asthma and to cure patients. A great number of 
genetic analyses have been conducted with asthma patients 
describing SNPs in the coding sequences of several proteins 
and intergenic, nontranslated regions close to protein coding 
sequences. During recent years, more than 100 candidate 
Table 2 gene ontology (gO) enrichment on the snP-related 
proteins and their first binding partners
GO-ID P-value x nX Description
5515 6.5707e-69 256 7023  Protein binding
4871 4.9020e-44 130 2217  signal transducer activity
6950 8.1435e-63 120 1258  Response to stress
19538 2.1909e-15 98 2768  Protein metabolic process
4872 2.9275e-20 84 1792  Receptor activity
5102 3.3451e-40 77 765  Receptor binding
166 3.8108e-3 50 2146  nucleotide binding
43234 8.1977e-5 48 1712  Protein complex
7267 3.5518e-16 40 535  cell–cell signaling
5509 1.1569e-8 40 932  calcium ion binding
16740 7.7375e-3 40 1693  Transferase activity
30528 5.7626e-3 35 1405  Transcription  
regulator activity
16265 2.2804e-12 33 485  Death
8219 2.2804e-12 33 485  cell death
16301 4.3301e-7 33 788  Kinase activity
30154 6.4206e-5 33 1001  cell differentiation
50222 4.2327e-9 31 580  Protein kinase activity
8233 6.9718e-7 28 616  Peptidase activity
16023 3.4546e-7 21 359  cytoplasmic membrane- 
bounded vesicle
6629 1.1188e-2 20 716  Lipid metabolic process
5768 2.8622e-8 18 228  endosome
8283 1.8276e-5 16 290  cell proliferation
8092 1.0819e-2 14 437  cytoskeletal  
protein binding
30246 8.7209e-4 13 292  carbohydrate binding
8289 8.3026e-3 13 380  Mol funct lipid binding
9719 5.2362e-6 11 125  Response to endogenous 
stimulus
3779 2.5076e-2 10 305  Actin binding
16032 3.2732e-5 7 57  Viral reproduction
Notes: go-iD is the gO class, x represents of the number of observed proteins 
in our data set, nX is the number of proteins in the background comparison dataset.
genes harboring these SNP modifications have been associ-
ated with bronchial asthma.
Our aim in the present work was to start a systems level 
analysis of the putative pathogenetic mechanisms involved in 
asthma. Databases, and especially their integrated and merged 
data warehouses, allow rapid and convenient access to the 
data publicly available. Furthermore, it is possible to integrate 
one’s own data on top of the publicly available data and thus 
enhance the level of information. In this study, starting with 
127 SNP-modified genes converted to the corresponding 
proteins obtained from published data, we could identify a 
protein–protein interaction network of over 1000 proteins.
Instead of focusing our analysis only on one or a few 
altered genes or their corresponding proteins, we attempted 
to generate larger protein–protein interaction networks 
from our data. No single database alone can provide such a 
connected network; in order to understand the new systems 
levels of diseases, we decided to build up an integrated data 
warehouse combining information from several databases. 
We are now able to show how the 127 proteins of asthma 
patients were connected together in a putative network. One 
of the most prominent observations in this network was that 
it was strongly enriched with protein binding, signal trans-
duction, and peptidase functions. The network contained 
several subnetworks enriched with toll-like receptors or 
chemokines.
The innate immune system responds to invading patho-
gens by activating a proinflammatory cascade aiming at 
eradicating the invading agents. Pattern recognition receptors 
are a crucial part of this innate immune reaction.19 A variety 
of intra- and extracellular pattern recognition receptors are 
known today, of which toll-like receptors are involved in 
the recognition of molecular structures specific for micro-
bial pathogens.20 Two main categories of toll-like receptors 
exist, ie, cell surface receptors and receptors localized in the 
endosome. It is important to make this distinction because 
surface toll-like receptors bind molecules on the bacterial 
cell wall, such as bacterial lipopeptides (TLR2) or lipopoly-
saccharide (TLR4), whereas endosomal toll-like receptors 
that are activated by microbial nucleic acids are less readily 
accessible.21
Research has shown that toll-like receptors can now be 
divided into two groups on the basis of their subcellular 
localization. The first group (TLR1, TLR2, TLR4, TLR5, and 
TLR6) is present on the surface of the cell, and recognizes 
lipid structures and, in the case of TLR5, the protein flagellin. 
The second group (TLR3, TLR7, TLR8, and TLR9) resides 
intracellularly and recognizes nucleic acids. The reason for Journal of Asthma and Allergy 2010:3 submit your manuscript | www.dovepress.com
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Figure 3 The chemokine network shows eight asthma-related single nucleotide polymorphism proteins (green nodes) binding to each other and their receptors (yellow 
nodes) found in the integrated protein interaction network analysis database.
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Figure 2 Sixty-five asthma-related single nucleotide polymorphism proteins showed interconnectivity; 14 interact with themselves, 20 form a pair, two triplets, one a quartet, 
and two larger networks contain several connected asthma-related single nucleotide polymorphism proteins. The chemokine network includes eight proteins and the toll-like 
receptor network 13 proteins which are all shown to carry asthma-related single nucleotide polymorphism modifications among their corresponding genes. Synonymous 
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the different localization of toll-like receptors may be that 
TLR1, TLR2, TLR4, TLR5, and TLR6 recognize markers 
on the surface of pathogens, while TLR3, TLR7, TLR8, and 
TLR9 recognize nucleic acids derived from the genome of 
viruses and bacteria. It has become increasingly apparent that 
the localization and traffic of toll-like receptors within the 
cell is an important mechanism whereby toll-like receptors 
sense their ligands. Importantly, the traffic of certain toll-like 
receptors during signaling can also prevent overactivation of 
the toll-like receptor signaling pathways.22
A small proportion of SNP mutations can cause the altered 
amino acid sequence in the corresponding protein directly. 
Genes that have previously been shown to have a SNP muta-
tion leading to a change in the actual protein structure and 
which have also been linked with asthma, are presented in red 
in Figure 4 (TLR1, TLR4, TLR5, TLR6, TLR10, and IL4R 
and IL13).23–26 Genes colored green have been shown to be 
asthma-related SNPs, but these SNP mutations do not have 
any effect on protein structures (IL4, STAT6, CD14, RIPK2, 
TLR2, TLR9). There are altogether 54 protein coding genes 
in the same pathway, with the aforementioned asthma-related 
genes having a SNP mutation (Figure 4).
The aberrant activation of toll-like receptor pathways, 
on the other hand, has been implicated in various chronic 
and autoimmune diseases affecting the gastrointestinal tract, 
central nervous system, kidneys, skin, lungs, and joints, 
whereby both exogenous and endogenous ligands have been 
suggested to act as toll-like receptor activators. The finding 
that intracellular proteins or the products of protein cleav-
age can act as endogenous ligands for toll-like receptors 
supports the hypothesis that toll-like receptors are important 
in mediating the response not only to infections but also to 
stress, damage, and death of cells in general.27
New developments in the fields of allergy and immunol-
ogy have yielded a variety of novel therapeutic approaches 
in recent years, resulting in more agents at the clinical 
trial stage as well. Among the therapeutic approaches 
are the toll-like receptor agonists, immunostimulatory 
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Figure 4 The toll-like receptor network displays 13 asthma-related single nucleotide polymorphism proteins (synonymous marked as green and nonsynonymous marked as 
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  oligodeoxynucleotides, oral and parenteral cytokine block-
ers, and specific cytokine receptor antagonists. However, a 
much better understanding of the “big picture of this systems 
inflammatory disease” must still be obtained before more 
target therapeutic approaches can be designed.28
Compared with the latest reports in which only one gene 
at a time has been in focus when analyzing the pathogenetic 
mechanisms of multifactorial diseases like asthma, we have 
now focused on the entire set of 127 genes and their corre-
sponding proteins. Of these 127 genes, 96 could be connected 
to a same gene-mRNA-protein and protein–protein interac-
tion network, and were found to be enriched significantly 
with protein binding, signal transduction, and endopeptidase 
activities. Taken together, we showed in this study using our 
in silico analysis framework and the outside databases that we 
can increase the level of knowledge by performing systems 
level analyses of previously characterized genes carrying 
SNPs related to asthma.
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Table 3 Forty interacting proteins from the toll-like receptor-pathway (Figure 4), which have been reported to carry altogether almost 
1000 nonsynonymous single nucleotide polymorphisms coding for alternative protein sequences
Gene SNP Type PMID
TLR1 rs5743594 intronic 18547625
rs5743595 intronic 18547625
rs4833095 nonsynonymous-coding 18547625
TLR2 rs4696480 intronic 18547625
rsl898830 intronic 18547625
rs3804099 synonymous-coding 18547625
rs2289318 upstream 19096003
TLR3 rs3775291 nonsynonymous-coding 18547625
TLR4 rs2737190 upstream 18547625
rsl0759932 upstream 18547625
rs4986791 nonsynonymous-coding 18547625
rsll536889 downstream/3prime utr 19096003
rs7045953 upstream 19096003
TLR5 rs5744168 stop gained 18547625
rs2072493 nonsynonymous-coding 18547625
rs5744174 nonsynonymous-coding 18547625
TLR6 rs5743789 upsream/intronic 18547625
rs5743819 nonsynonymous-coding 18547625
TLR7 rsl79008 nonsynonymous-coding 18547625, 18682521
TLR8 rs3761624 upstream 18547625
rs2407992 synonymous-coding 18682521
TLR9 rsl87084 upstream 18547625, 19247692
rs5743836 upstream 18547625
rs352143 upstream 19096003
rs352163 upstream 19096003
rs353547 downstream 19096003
TLR10 rsll096956 synonymous-coding 18547625
rs4129009 nonsynonymous-coding 18547625
rsll09657 nonsynonymous-coding 19247692
iL13 rsl881457 within_non_coding_gene/upsteam 19796199
rsl800925 within_non_coding_gene/upsteam 19796199
rs2243204 downstream 19247692
rsl295686 within noncoding gene/intronic 19247692
rs20541 nonsynonymous-coding/within_non_coding_gene 19254294
iL4 rs2243250 upstream 18263811
iL4RA rsl805010 non_synonymous_coding/downstream 19796199
sTAT6 rs324015 3prime-utr 19247692
rs324011 intronic 19247692
RiPK2 rs2293807 downstream 17075290
cD14 rs2569190 3prime_utr/intronic 18925877Journal of Asthma and Allergy 2010:3 submit your manuscript | www.dovepress.com
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